default author photo

Laurens Liesenborghs

KU Leuven - Rega Institute for Medical Research

Leuven

Belgium

SCHOLARLY PAPERS

4

DOWNLOADS

747

TOTAL CITATIONS

4

Scholarly Papers (4)

1.

Mpox in the Democratic Republic of Congo: Analysis of National Epidemiological and Laboratory Surveillance Data, 2010 - 2023

Number of pages: 30 Posted: 19 Sep 2024
Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Democratic Republic of Congo - Ministry of Health, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, University of Antwerp - Department of Clinical Sciences, University of Antwerp - Department of Clinical Sciences, University of Antwerp - Department of Clinical Sciences, University of Antwerp - Department of Clinical Sciences, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Kinshasa School of Public Health, Kinshasa School of Public Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), Government of the United States of America - Centers for Disease Control and Prevention (CDC), University of California, Los Angeles (UCLA) - Department of Epidemiology, University of California, Los Angeles (UCLA) - Department of Epidemiology, University of Manitoba - Department of Infectious Diseases and Medical Microbiology, University of Montpellier, University of Bern - Institute of Social and Preventive Medicine, Government of the United States of America - Division of High Consequence Pathogens and Pathology, Democratic Republic of Congo - Ministry of Health, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, National Multisectoral Committee for Ebola Response, KU Leuven - Rega Institute for Medical Research and Institut National de Recherche Biomédicale
Downloads 343 (217,753)
Citation 3

Abstract:

Loading...

Mpox, Monkeypox virus, Incidence, Surveillance, Mpox Confirmatory Testing, DR Congo

2.

Maternal and Neonatal Outcomes after Clade I Mpox Virus Infection In Pregnancy: A Pooled Prospective Observational Study in the Democratic Republic of the Congo

Number of pages: 36 Posted: 09 Oct 2025
Institut National de Recherche Biomédicale, Université Catholique de Bukavu, Institut National de Recherche Biomédicale, Université Catholique de Bukavu, University of Bern - Institute of Social and Preventive Medicine, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, University of Antwerp - Department of Clinical Sciences, Nagasaki University - Institute of Tropical Medicine, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, University of Antwerp - Global Health Institute, Université de Kinshasa, Institut National de Recherche Biomédicale, Université Catholique de Bukavu, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Université Catholique de Bukavu, Université de Kinshasa, Makerere University - Makerere University Lung Institute, Makerere University - Department of Immunology and Molecular Biology, University of Antwerp - Global Health Institute, Université Catholique de Bukavu, University of California, Los Angeles (UCLA) - Department of Epidemiology, Institut National de Recherche Biomédicale, University of Antwerp - Department of Clinical Sciences, Institut National de Recherche Biomédicale, Université de Kinshasa - Département de Microbiologie, University of Hamburg - Institute of Neuropathology, University of Manitoba - Department of Infectious Diseases and Medical Microbiology, Johns Hopkins University - Bloomberg School of Public Health, Government of the United States of America - National Institute of Allergy and Infectious Diseases, University of Otago - Christchurch Hospital, University of North Carolina (UNC) at Chapel Hill - National Institute of Health, Government of the United States of America - Centers for Disease Control and Prevention (CDC), Independent, Independent, Independent, Independent, University of Bern - Institute of Social and Preventive Medicine, Université Catholique de Bukavu, Institut National de Recherche Biomédicale and KU Leuven - Rega Institute for Medical Research
Downloads 194 (391,686)

Abstract:

Loading...

Monkeypox virus (MPXV), mpox, Clade I, Pregnancy, Maternal outcomes, Neonatal outcomes, Adverse pregnancy outcomes, Vertical transmission, Fetal loss, Stillbirth, Spontaneous abortion, Congenital infection, Democratic Republic of the Congo, Observational cohort study

3.

Itraconazole for COVID-19: Preclinical Studies and a Proof-of-Concept Pilot Clinical Study

Number of pages: 32 Posted: 10 Dec 2020
KU Leuven - Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, KU Leuven - Leuven Biostatistics and Statistical Bioinformatics Centre, Department of Respiratory Diseases, UZ Leuven and CHROMETA, Research group BREATHE, KU Leuven, Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, KU Leuven - Department of Pharmaceutical and Pharmacological SciencesKU Leuven - Department of Pharmaceutical and Pharmacological Sciences, KU Leuven - Department of Oncology, Department of Cardiovascular Sciences, UZ and KU Leuven, Department of Oncology, Laboratory for molecular Cancer biology, VIB-KULeuven, Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, Department of General Internal Medicine, UZ Leuven and Department of Microbiology, Immunology and Transplantation, KU Leuven, Department of Cardiovascular Sciences, UZ and KU Leuven, Department of Cardiovascular Sciences, UZ and KU Leuven, Pharmacy Department University Hospitals Leuven and Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Translational Cell and Tissue Research, Department of Imaging and Pathology, Katholieke Universiteit Leuven, KU Leuven - Department of Cardiovascular Medicine, Pharmacy Department University Hospitals Leuven and Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Intensive Care Medicine, UZ and KU Leuven, KU Leuven- Respiratory Division and Rehabilitation, Department of Respiratory Diseases, UZ Leuven and CHROMETA, Research group BREATHE, KU Leuven, Department of Cardiovascular Sciences and Clinical Department of Laboratory Medicine, KU Leuven, KU Leuven - University Hospitals Leuven, KU Leuven, Department of General Internal Medicine, UZ Leuven and Department of Microbiology, Immunology and Transplantation, KU Leuven, KU Leuven, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, KU Leuven, KU Leuven - Laboratory of Virology and Chemotherapy and KU Leuven - Division of Cardiology
Downloads 181 (418,025)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, itraconazole, drug repurposing, antivirals

4.

Clinical Features and Outcomes Associated with a Clade IIb Mpox Virus Outbreak in Sierra Leone, Jan-Aug 2025

Number of pages: 29 Posted: 05 Jun 2026
University of Sierra Leone, Institut National de Recherche Biomédicale, Institut National de Recherche Biomédicale, Government of Sierra Leone, Njala University, University of Sierra Leone - College of Medicine and Allied Health Sciences, Government of Sierra Leone - Ministry of Health and Sanitation, Government of Sierra Leone, Government of Sierra Leone, University of Port Harcourt - University of Port Harcourt Teaching Hospital, University of Port Harcourt - University of Port Harcourt Teaching Hospital, Nagasaki University - Institute of Tropical Medicine, University of Antwerp - Department of Clinical Sciences, Sciensano, University of Manitoba - Department of Infectious Diseases and Medical Microbiology, Government of Sierra Leone - Ministry of Health and Sanitation, Government of Sierra Leone - Ministry of Health and Sanitation, Government of Sierra Leone - Ministry of Health and Sanitation, Government of Sierra Leone - Ministry of Health and Sanitation, Government of Sierra Leone - Ministry of Health and Sanitation, Government of Sierra Leone - Ministry of Health and Sanitation, Cyprus International University, KU Leuven - Rega Institute for Medical Research and University of Sierra Leone - College of Medicine and Allied Health Sciences
Downloads 29

Abstract:

Loading...

Mpox, Clade IIb MPXV, Sierra Leone, HIV, CD4 lymphocyte count, Disease severity, Mortality, Sexual transmission, Clinical outcomes, Heterosexual transmission, Outbreak epidemiology